Get started
Author

Charles Ebuka Okafor

Observed names: C E Okafor, C Okafor, C. E. Okafor, C. Okafor, CE Okafor, Charles E Okafor, Charles E. Okafor, Charles Okafor, OKAFOR CE, Okafor, Charles, Okafor, Charles E, Okafor, Charles E., Okafor, Charles Ebuka
ORCID: 0000-0002-7048-910X
Observed ORCID: 0000-0002-7048-910X
OpenAlex ID: A5033703941
Formulation and in vitro evaluation of a PEGylated microscopic lipospheres delivery system for ceftriaxone sodium
2009 · A. A. Attama, C. E. Okafor, et al. · Drug Delivery · 73
PDF
Deriving an optimal threshold of waist circumference for detecting cardiometabolic risk in sub-Saharan Africa
2017 · K Ekoru, G A V Murphy, et al. · International Journal of Obesity · 68
PDF
Cost of septic and aseptic revision total knee arthroplasty: a systematic review
2021 · Charles Okafor, Brent Hodgkinson, et al. · BMC Musculoskeletal Disorders · 66
PDF
One-stage revision versus debridement, antibiotics, and implant retention (DAIR) for acute prosthetic knee infection: an exploratory cohort study
2023 · Charles Ebuka Okafor, Son Nghiem, et al. · Archives of Orthopaedic and Trauma Surgery · 37
PDF
Interventions to increase mammography screening uptake among women living in low-income and middle-income countries: a systematic review
2023 · Ifeoma Jovita Nduka, Izuchukwu Loveth Ejie, et al. · BMJ Open · 20
PDF
Cost-utility analysis of antihypertensive medications in Nigeria: a decision analysis
2013 · Obinna Ikechukwu Ekwunife, Charles E Okafor, et al. · Cost Effectiveness and Resource Allocation · 20
PDF
Is 2-Stage Septic Revision Worth the Money? A Cost-Utility Analysis of a 1-Stage Versus 2-Stage Septic Revision of Total Knee Arthroplasty
2022 · Charles E. Okafor, Son Nghiem, et al. · The Journal of Arthroplasty · 19
PDF
Introducing rotavirus vaccine in eight sub-Saharan African countries: a cost–benefit analysis
2021 · Charles E Okafor, Obinna I Ekwunife · The Lancet Global Health · 16
PDF
Cost-Consequence Analysis of Deprescribing to Optimize Health Outcomes for Frail Older People: A Within-Trial Analysis
2024 · Charles E. Okafor, Syed Afroz Keramat, et al. · Journal of the American Medical Directors Association · 15
Cost-effectiveness and feasibility of conditional economic incentives and motivational interviewing to improve HIV health outcomes of adolescents living with HIV in Anambra State, Nigeria
2021 · Obinna Ikechukwu Ekwunife, Chinelo Janefrances Ofomata, et al. · BMC Health Services Research · 13
PDF
Are joint replacement registries associated with burden of revision changes? A real-world panel data regression analysis
2023 · Charles Ebuka Okafor, Son Nghiem, et al. · BMJ Open · 10
PDF
Cost-effectiveness analysis of diarrhoea management approaches in Nigeria: A decision analytical model
2017 · Charles E. Okafor, Obinna I. Ekwunife · PLoS neglected tropical diseases · 10
PDF
Introducing Rotavirus Vaccination in Nigeria: Economic Evaluation and Implications
2021 · Charles Ebuka Okafor · PharmacoEconomics - Open · 9
PDF
Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis
2024 · Ming G. Chai, Quyen Tu, et al. · Intensive Care Medicine · 8
PDF
Cost Effectiveness of Strategies to Manage Atrial Fibrillation in Middle- and High-Income Countries: A Systematic Review
2023 · Charles Okafor, Joshua Byrnes, et al. · PharmacoEconomics · 8
PDF
Cost-benefit analysis of a population-based prostate-specific antigen mass testing for early detection of prostate cancer in Anambra State, Nigeria: A health provider's perspective
2022 · Victor Abhulimen, IfeomaBlessing Umeh, et al. · Nigerian Journal of Medicine · 5
Cost of Revision Total Knee Replacement: A Protocol for Systematic Review and Meta-Analysis
2020 · Charles Ebuka Okafor, Son Nghiem, et al. · PharmacoEconomics - Open · 5
PDF
Are joint replacement registries cost-effective? Economic evaluation of the Australian orthopaedic association National joint replacement registry
2025 · Charles Okafor, Son Nghiem, et al. · Archives of Orthopaedic and Trauma Surgery · 4
PDF
Are Updated COVID-19 Vaccines Still Relevant for All Adult Age Groups? An Economic Evaluation of the Monovalent XBB.1.5 Vaccine in Australia
2025 · Charles Ebuka Okafor, Syed Afroz Keramat, et al. · Value in Health · 4
PDF
Promoting the integrated community case management of pneumonia in children under 5 years in Nigeria through the proprietary and patent medicine vendors: a cost-effectiveness analysis
2021 · Charles E. Okafor, Obinna I. Ekwunife, et al. · Cost Effectiveness and Resource Allocation · 4
PDF
Cost-utility of burns management in Nigeria: a case study of the National Orthopaedic Hospital, Enugu.
2017 · C E Okafor, O Onunka, et al. · PubMed · 3
Co‐Producing and Evaluating a Culturally Inclusive Dementia Education Initiative: A Multimethod Study Protocol
2025 · Gabriela Caballero, Ann Dadich, et al. · Health Expectations · 2
PDF
Healthcare spending and factors associated with fall injury in Australia residential aged care: a cohort analysis
2025 · Charles Okafor, Namal N. Balasooriya, et al. · Injury Prevention · 2
Interventions to increase mammography screening uptake among women living in low-income and middle-income countries: a protocol for a systematic review
2022 · Ifeoma Jovita Nduka, Izuchukwu Loveth Ejie, et al. · BMJ Open · 2
PDF
Psychosocial Factors and Bowel Cancer Screening Among Middle-Aged and Older Australians: Evidence From a Population-Based Longitudinal Study
2025 · Syed Afroz Keramat, Charles E. Okafor, et al. · American Journal of Health Promotion · 1
Works count: 48
Citation count: 425
H-index: 10
I10-index: 12
Year
Topic
Type